Aciphex

Waylis Therapeutics LLC🇺🇸 United States

FDA Page

Effective Date: Nov 22, 2023
Approval ID: 1eb38279-0237-4967-be7a-c53a826c1138
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ACIPHEX DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for ACIPHEX DELAYED-RELEASE TABLETS. ACIPHEX (rabeprazole sodium) delayed-release tablets, for oral use Initial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.